Clinical Trials

NCT07267000 | RECRUITING | NA
50 participants

EXERCISE AND THE IMMUNE RESPONSE IN LUNG CANCER

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2026-04-01
Completion:
2028-10-01
Conditions
  • Non-Small Cell Lung Cancer
  • Exercise Training
  • Immunotherapy
  • Small Cell Cancer Of The Lung
Interventions
  • OTHER
  • BEHAVIORAL
No Results Yet
NCT07259304 | RECRUITING
250 participants

Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors

Study Type:
OBSERVATIONAL
Last Updated:
2026-05-28
Start Date:
2021-11-24
Completion:
2026-12-31
Conditions
  • Stage I Cervical Cancer AJCC v8
  • Anatomic Stage I Breast Cancer AJCC v8
  • Anatomic Stage IA Breast Cancer AJCC v8
  • Anatomic Stage IB Breast Cancer AJCC v8
  • Anatomic Stage II Breast Cancer AJCC v8
  • Anatomic Stage IIA Breast Cancer AJCC v8
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • Anatomic Stage III Breast Cancer AJCC v8
  • Anatomic Stage IIIA Breast Cancer AJCC v8
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • Anatomic Stage IIIC Breast Cancer AJCC v8
  • Central Nervous System Neoplasm
  • Clinical Stage I Cutaneous Melanoma AJCC v8
  • Clinical Stage IA Cutaneous Melanoma AJCC v8
  • Clinical Stage IB Cutaneous Melanoma AJCC v8
  • Clinical Stage II Cutaneous Melanoma AJCC v8
  • Clinical Stage IIA Cutaneous Melanoma AJCC v8
  • Clinical Stage IIB Cutaneous Melanoma AJCC v8
  • Clinical Stage IIC Cutaneous Melanoma AJCC v8
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • Hodgkin Lymphoma
  • Malignant Bone Neoplasm
  • Malignant Brain Neoplasm
  • Malignant Solid Neoplasm
  • Malignant Testicular Neoplasm
  • Non-Hodgkin Lymphoma
  • Pathologic Stage I Cutaneous Melanoma AJCC v8
  • Pathologic Stage IA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IB Cutaneous Melanoma AJCC v8
  • Pathologic Stage II Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage III Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIA Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIIC Cutaneous Melanoma AJCC v8
  • Pathologic Stage IIID Cutaneous Melanoma AJCC v8
  • Prognostic Stage I Breast Cancer AJCC v8
  • Prognostic Stage IA Breast Cancer AJCC v8
  • Prognostic Stage IB Breast Cancer AJCC v8
  • Prognostic Stage II Breast Cancer AJCC v8
  • Prognostic Stage IIA Breast Cancer AJCC v8
  • Prognostic Stage IIB Breast Cancer AJCC v8
  • Prognostic Stage III Breast Cancer AJCC v8
  • Prognostic Stage IIIA Breast Cancer AJCC v8
  • Prognostic Stage IIIB Breast Cancer AJCC v8
  • Prognostic Stage IIIC Breast Cancer AJCC v8
  • Stage I Colorectal Cancer AJCC v8
  • Stage I Differentiated Thyroid Gland Carcinoma AJCC v8
  • Stage I Ovarian Cancer AJCC v8
  • Stage I Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage I Uterine Corpus Cancer AJCC v8
  • Stage IA Cervical Cancer AJCC v8
  • Stage IA Ovarian Cancer AJCC v8
  • Stage IA Uterine Corpus Cancer AJCC v8
  • Stage IA1 Cervical Cancer AJCC v8
  • Stage IA2 Cervical Cancer AJCC v8
  • Stage IB Cervical Cancer AJCC v8
  • Stage IB Ovarian Cancer AJCC v8
  • Stage IB Uterine Corpus Cancer AJCC v8
  • Stage IB1 Cervical Cancer AJCC v8
  • Stage IB2 Cervical Cancer AJCC v8
  • Stage IC Ovarian Cancer AJCC v8
  • Stage II Cervical Cancer AJCC v8
  • Stage II Colorectal Cancer AJCC v8
  • Stage II Differentiated Thyroid Gland Carcinoma AJCC v8
  • Stage II Ovarian Cancer AJCC v8
  • Stage II Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage II Uterine Corpus Cancer AJCC v8
  • Stage IIA Cervical Cancer AJCC v8
  • Stage IIA Colorectal Cancer AJCC v8
  • Stage IIA Ovarian Cancer AJCC v8
  • Stage IIA1 Cervical Cancer AJCC v8
  • Stage IIA2 Cervical Cancer AJCC v8
  • Stage IIB Cervical Cancer AJCC v8
  • Stage IIB Colorectal Cancer AJCC v8
  • Stage IIB Ovarian Cancer AJCC v8
  • Stage IIC Colorectal Cancer AJCC v8
  • Stage III Cervical Cancer AJCC v8
  • Stage III Colorectal Cancer AJCC v8
  • Stage III Differentiated Thyroid Gland Carcinoma AJCC v8
  • Stage III Ovarian Cancer AJCC v8
  • Stage III Thyroid Gland Medullary Carcinoma AJCC v8
  • Stage III Uterine Corpus Cancer AJCC v8
  • Stage IIIA Cervical Cancer AJCC v8
  • Stage IIIA Colorectal Cancer AJCC v8
  • Stage IIIA Ovarian Cancer AJCC v8
  • Stage IIIA Uterine Corpus Cancer AJCC v8
  • Stage IIIA1 Ovarian Cancer AJCC v8
  • Stage IIIA2 Ovarian Cancer AJCC v8
  • Stage IIIB Cervical Cancer AJCC v8
  • Stage IIIB Colorectal Cancer AJCC v8
  • Stage IIIB Ovarian Cancer AJCC v8
  • Stage IIIB Uterine Corpus Cancer AJCC v8
  • Stage IIIC Colorectal Cancer AJCC v8
  • Stage IIIC Ovarian Cancer AJCC v8
  • Stage IIIC Uterine Corpus Cancer AJCC v8
  • Stage IIIC1 Uterine Corpus Cancer AJCC v8
  • Stage IIIC2 Uterine Corpus Cancer AJCC v8
Interventions
  • OTHER
No Results Yet
NCT07240818 | NOT_YET_RECRUITING | NA
30 participants

Comparison of FNB to EUS-CNB for Pancreatic Lesions

Study Type:
INTERVENTIONAL
Last Updated:
2026-05-28
Start Date:
2026-05-01
Completion:
2026-11-01
Conditions
  • Diagnosis of a Pancreaticobiliary Disorder
  • Biopsy
  • EUS Guided Biopsy
Interventions
  • DEVICE
  • PROCEDURE
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page